Literature DB >> 7764094

Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli.

P J Schatz1.   

Abstract

I describe a technique for screening peptide libraries of over 10(9) independent clones for substrates of peptide-modifying enzymes. The peptides, linked to their genetic material by the lac repressor, are exposed to the enzyme and then screened by affinity purification on a receptor specific for the modified product. The enzyme characterized, E. coli biotin holoenzyme synthetase, normally adds biotin to a specific lysine residue in complex protein domains. The 13 residue substrate identified by this library screening approach is much smaller than the 75 amino acid required sequence of the natural substrate, and can function at either end of a fusion protein. The sequence is quite distinct at some positions from that region of the natural substrates, presumably because the peptides have to mimic the folded structure formed by the natural substrate. This technique should be useful for mapping the substrate specificity of a variety of peptide-modifying enzymes. In addition, small peptide substrates that are enzymatically biotinylated at a single site should be useful for a variety of purposes in labeling, purification, detection, and immobilization of proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7764094     DOI: 10.1038/nbt1093-1138

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  181 in total

1.  An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro.

Authors:  W Rees; J Bender; T K Teague; R M Kedl; F Crawford; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.

Authors:  E J Novak; A W Liu; G T Nepom; W W Kwok
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

3.  A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation.

Authors:  D Beckett; E Kovaleva; P J Schatz
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

4.  Coordination of kinesin's two heads studied with mutant heterodimers.

Authors:  Kuniyoshi Kaseda; Hideo Higuchi; Keiko Hirose
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

5.  Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer.

Authors:  J Colin Cox; Andrew Hayhurst; Jay Hesselberth; Travis S Bayer; George Georgiou; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

6.  Metabolic biotinylation of recombinant proteins in mammalian cells and in mice.

Authors:  M B Parrott; M A Barry
Journal:  Mol Ther       Date:  2000-01       Impact factor: 11.454

7.  Differential effects of supplementary affinity tags on the solubility of MBP fusion proteins.

Authors:  Karen M Routzahn; David S Waugh
Journal:  J Struct Funct Genomics       Date:  2002

8.  Biotin-tagged cDNA expression libraries displayed on lambda phage: a new tool for the selection of natural protein ligands.

Authors:  Helenia Ansuini; Carla Cicchini; Alfredo Nicosia; Marco Tripodi; Riccardo Cortese; Alessandra Luzzago
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

9.  Src kinase activation by direct interaction with the integrin beta cytoplasmic domain.

Authors:  Elena G Arias-Salgado; Sergio Lizano; Sugata Sarkar; Joan S Brugge; Mark H Ginsberg; Sanford J Shattil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

10.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

Authors:  Thomas Stratmann; Natalia Martin-Orozco; Valérie Mallet-Designe; Laurent Poirot; Dorian McGavern; Grigoriy Losyev; Cathleen M Dobbs; Michael B A Oldstone; Kenji Yoshida; Hitoshi Kikutani; Diane Mathis; Christophe Benoist; Kathryn Haskins; Luc Teyton
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.